Survival benefit with checkpoint inhibitors versus chemotherapy is modified by brain metastases in patients with recurrent small cell lung cancer

ABSTRACT:

SUBMITTER: Althoff F 

PROVIDER: S-EPMC10556470 | biostudies-literature | 2023 Jan

REPOSITORIES: biostudies-literature